Skip to main content
Equibles
MD logo

MD · Pediatrix Medical Group, Inc.

Track MD — free

Use MD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about MD

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$26.60 -0.21 (-0.76%) At close · Aug 28
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.18B
Shares
81.25M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$26.80 Open$26.79 Day$26.63–26.92 52W close$15.80–27.39 Avg vol 30d758K Short int4.9M · 6.1% float · 5.4d Short vol51% Last earningsJul 15, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 4

Up next

Next earnings call
Oct 6, 2026 Est · unconfirmed · in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 4, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Moderate
      Market backdrop VIX 14.4 · calm Equity put/call 0.39
      Technical
      price trend
      Strong Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +17%
      above
      Price vs 50-day avg +3%
      above
      RSI (14) 55
      neutral
      MACD trend Positive
      52-week position 95%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +1%
      trailing
      6-month return +36%
      trailing
      YTD return +25%
      this year
      Relative strength +21%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $26 › 200d $23 — 50d above 200d
      Institutional flow Accumulating
      +2% holders QoQ · +42 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      6.08% of float · ▲ +19.4% MoM · 5.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      301 holders — near 3-yr high, broad support
      Squeeze score 66
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −5%
      Y/Y
      EPS growth +263%
      Y/Y
      Valuation P/E 12.8
      below peers
      Buyback $104.5M
      remaining
      Balance sheet $225.0M
      net debt
      Quant / Vol
      risk profile
      Moderate
      Volatility 43%
      annualized · 1-yr
      Max drawdown −24%
      past year
      ATR 3.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 4, 2026
      Adjusted EBITDA · full year 2026 Non-GAAP Maintained $280M – $300M
      Jul 15, 2026 $280M – $300M changed to Aug 4, 2026 $280M – $300M
      Prior guidance period ended · from the Earnings Call filed Dec 31, 2025
      Adjusted EBITDA · first quarter 2026 (as a percentage of full-year 2026 adjusted E 17% – 19%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +17% Bullish
      Price vs 50-day avg
      +3% Bullish
      RSI (14)
      55 Neutral
      MACD trend
      Positive Bullish
      52-week position
      95% Bullish
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $26 › 200d $23 — 50d above 200d
      Institutional flow Accumulating
      +2% holders QoQ · +42 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      6.08% of float · ▲ +19.4% MoM · 5.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      301 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $16 Now $27 · 95% Range high $27
      vs 200-day avg +17% vs 50-day avg +3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Cash from continuing operations $126.3M Three Months Ended June 30, 2026 —
      Hospital-based patient services same-unit volume -2.2% Six Months Ended June 30, 2026 —
      Neonatal intensive care unit (NICU) days same-unit volume -2% Six Months Ended June 30, 2026 —
      Office-based patient services same-unit volume -2.4% Six Months Ended June 30, 2026 —
      Affiliated physicians and other clinicians 4,300 as of May 5, 2026 —
      Hospital-based patient services -1.5% Three Months Ended March 31, 2026 —
      Office-based patient services -3.3% Three Months Ended March 31, 2026 —
      Same-unit revenue 2.8% three months ended March 31, 2026 —
      Same-unit net revenue growth 4% Three Months Ended December 31, 2025 —
      Same-unit revenue attributable to patient service volumes 2.7% Three Months Ended December 31, 2025 —
      Same-unit volume: Hospital-based patient services 0.7% Twelve Months Ended December 31, 2025 —
      Same-unit volume: Neonatal intensive care unit (NICU) days -2% Three Months Ended December 31, 2025 —
      Same-unit volume: Office-based patient services 0.5% Twelve Months Ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Care Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      MD
      Pediatrix Medical Group, Inc.
      this stock
      		$2.18B +25.3% -4.9% 12.8 6.1%
      HCA
      HCA Healthcare, Inc.
      		 $93.03B -10.2% +7.1% 14.5 2.8%
      FSNUY
      Fresenius SE & Co. KGaA
      		 $30.21B -6.4% — — 0.0%
      THC
      Tenet Healthcare Corp
      		 $21.48B +34.7% +0.9% 10.3 3.1%
      FMS
      Fresenius Medical Care AG
      		 $12.38B -2.3% +5.9% — 0.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      301
      % held
      102.7%
      Net QoQ
      +413.2K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      352
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      4.9M
      Days to cover
      5.4d
      Change
      +803.8K sh
      View
      Short Volume
      Short vol %
      51%
      As of
      Aug 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2
      Value
      $53
      As of
      Jul 27, 2026
      View
      Off-Exchange
      Off-exchange %
      37.0%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Donna Shalala
      Amount
      $50.0K–$100.0K
      Traded
      Oct 15, 2019
      View
      Financials
      Financials
      Net income (FY)
      $165.4M
      EPS diluted
      $1.94
      View
      Buybacks
      Authorized
      $250.0M
      Remaining
      $104.5M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 4, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $853.1K
      Shares
      36.0K
      Filed
      May 13, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 15, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      MD +2.2% +1.2% +35.7% +1.1% +25.3%
      SPY +1.1% +4.0% +14.7% +3.2% +13.1%
      vs SPY +1.1% -2.8% +21.0% -2.1% +12.2%

      Capital returns

      Buyback program · as of Jun 30, 2026
      Authorized
      $250.00M
      Spent (derived)
      $145.50M
      Remaining
      $104.50M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 893949 CUSIP 58502B106 13F (30d) 247 filings 247 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)